Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.

Antimicrobial agents and chemotherapy - 1 Dec 2007

Japrung Deanpen, Leartsakulpanich Ubolsree, Chusacultanachai Sudsanguan, Yuthavong Yongyuth

Abstract excerpt

Plasmodium falciparum strains bearing quadruple mutations of dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) at codons 51, 59, 108, and 164 are highly resistant to pyrimethamine (PYR), a diaminopyrimidine, but sensitive to WR99210 (WR), a cycloguanil analog, suggesting different enzyme-i...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Drug Resistance
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasmodium falciparum

Share to Proguanil

Share to Pyrimethamine

Share to Tetrahydrofolate Dehydrogenase

Share to Triazines

Source

Open in PubMed Open full text

Identifiers

PMID: 17875995
DOI: 10.1128/AAC.00577-07
PMCID: PMC2167985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17875995-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.PMID 17875995Read ↗

Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli.Semantic proximity Read ↗

Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.Semantic proximity Read ↗

Antifolate-resistant mutants of <i>Plasmodium falciparum</i> dihydrofolate reductaseSemantic proximity Read ↗

Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.Semantic proximity Read ↗

Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.Semantic proximity Read ↗

Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210.Semantic proximity Read ↗

In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.Semantic proximity Read ↗

Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.Semantic proximity Read ↗

Identification of the optimal third generation antifolate against P. falciparum and P. vivax.Semantic proximity Read ↗

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetSemantic proximity Read ↗

Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria.Semantic proximity Read ↗

Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.